Pharmacokinetics of Sulforaphane from Natural Broccoli Sprout Supplements in Pregnancy.

Not Applicable

Withdrawn

• Conditions: Pre-eclampsia.; Reproductive Health and Childbirth - Normal pregnancy; Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy

• Registration Number: ACTRN12617001100381
• Lead Sponsor: Monash Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-28
• Last Update Posted: 29 June 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Female
• Target Recruitment: 6

Inclusion Criteria

Healthy, pregnant with a singleton fetus between 24 to 36 weeks gestation.

Able to read and understand the Patient Information and Consent Form, and to provide written, informed consent.

Exclusion Criteria

Pregnant women who are taking a medication, or who have a medical or pregnancy related condition, that may have the potential to interfere with the pharmacokinetics of the broccoli sprout supplement.

Study & Design

• Study Type: Interventional
• Study Design: Not specified